APOTHEEK BROOTHAERTS
ActiveThe computed 12-month bankruptcy probability of APOTHEEK BROOTHAERTS is 1.7% (moderate). The 2025 annual accounts show equity of €223k and a net result of €84k. Equity is growing by ~58.8% per year across the filed fiscal years. Its solvency ranks better than 40% of 18120 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
63
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability79=
Solvency47▲+8
Growth78=
Track record94
Bankruptcy probability, 12 months
1.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €14k at 30 days acceptable
Liquidity ample (current ratio 3.04 against 2.51 in 2024; short-term debt: 12.2% and cash: 9.6% of total assets), but 78.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
21.9%
Return on assets
8.2%
Age of the figures
15 mo
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-02-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filingsDeviation from the deadline
2025
27 d late
2024
10 d early
2023
19 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close19-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€223k▲ 60.2%
2024 · €139k
2023: €59k
2024: €139k
2023 → 2025
Total assets
€1.02M▲ 4.5%
2024 · €977k
2023: €985k
2024: €977k
2023 → 2025
Net result
€84k▲ 5.0%
2024 · €80k
2023: €9k
2024: €80k
2023 → 2025
Working capital
€254k▲ 46.0%
2024 · €174k
2023: €101k
2024: €174k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€59k-€139k▲ 135%€223k▲ 60.2%
Operating result€25k-€114k▲ 358%€122k▲ 6.4%
Net result€9k-€80k▲ 749%€84k▲ 5.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 6% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.02M
Fixed assets
€643k▼ 6.5%
Current assets
€378k▲ 30.7%
Equity and liabilities €1.02M
Equity
€223k▲ 60.2%
Debt
€797k▼ 4.8%
The debt ratio falls from 85.7% to 78.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€168k▲
2024 · €161k
Cash flow
€131k▲
2024 · €126k
Solvency
21.9%▲
2024 · 14.3%
Current ratio
3.04▲
2024 · 2.51
Quick ratio
1.95▲
2024 · 1.36
Debt / equity
3.57▼
2024 · 6.01
ROE
37.6%▼
2024 · 57.4%
ROA
8.2%▲
2024 · 8.2%
Interest coverage
10.16▼
2024 · 10.34
Debt
€797k▼
2024 · €837k
Debt ≤ 1 year
€124k▲
2024 · €115k
Debt > 1 year
€666k▼
2024 · €717k
Income taxes
€22k▲
2024 · €20k
Staff costs
€73▼
2024 · €331
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€977k€1.02M▲
Fixed assets21/28€688k€643k▼
Intangible fixed assets21€210k€184k▼
Tangible fixed assets22/27€477k€458k▼
Land and buildings22€432k€425k▼
Plant, machinery and equipment23€43k€31k▼
Furniture and vehicles24€2k€2k▼
Current assets29/58€289k€378k▲
Stocks and contracts in progress3€132k€136k▲
Stocks30/36€132k€136k▲
Amounts receivable within one year40/41€43k€65k▲
Trade receivables40€42k€65k▲
Other amounts receivable41€201-
Current investments50/53-€75k
Cash at bank and in hand54/58€111k€98k▼
Deferred charges and accrued income490/1€3k€5k▲
Equity and liabilities
Total equity and liabilities10/49€977k€1.02M▲
Equity10/15€139k€223k▲
Contributions10/11€50k€50k=
Profit (loss) carried forward14€89k€173k▲
Amounts payable17/49€837k€797k▼
Amounts payable after more than one year17€717k€666k▼
Financial debts170/4€717k€666k▼
Amounts payable within one year42/48€115k€124k▲
Current portion of amounts payable after more than one year42€50k€50k▲
Trade debts44€41k€44k▲
Suppliers440/4€41k€44k▲
Taxes, remuneration and social security45€20k€26k▲
Taxes450/3€20k€23k▲
Remuneration and social security454/9-€4k
Other amounts payable47/48€4k€4k▼
Accrued charges and deferred income492/3€5k€7k▲
Income statement
Code20242025
Remuneration, social security and pensions62€331€73▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€46k€47k▲
Other operating charges640/8€2k€852▼
Gross operating margin9900€163k€169k▲
Operating profit (loss)9901€114k€122k▲
Financial income75/76B€2k€1k▼
Recurring financial income75€2k€1k▼
Financial charges65/66B€16k€17k▲
Recurring financial charges65€16k€17k▲
Profit (loss) for the period before taxes9903€100k€106k▲
Income taxes67/77€20k€22k▲
Profit (loss) for the period9904€80k€84k▲
Profit (loss) for the period to be appropriated9905€80k€84k▲
Appropriation of the result
Profit (loss) to be appropriated9906€89k€173k▲
Profit (loss) brought forward from the previous period14P€9k€89k▲
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
30-06
Financial
Highest result since 2023net €84k ▲5%
Operating result €122k, net result €84k, both a record.
30-06
Financial
Equity above €200kEq €223k ▲60.2%
3 profitable years in a row build equity to €223k.
21-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Equity above €100kEq €139k ▲135%
2 profitable years in a row build equity to €139k.
12-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Willebroek · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Jozef De Blockstraat 192830 WillebroekGround area
361 m²
Building footprint
90 m²
Volume, LiDAR
644 m³
Parcel 12036A0378/00K004, Flanders · tallest building 11.0 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK BROOTHAERTS
since 20222.332.095.774
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12036A0378/00K004 | Flanders | 361 m² | 1 · 90 m² | 11.0 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteWillebroek2.332.095.774
Similar companies · same sector, comparable size
DISTEPHAR
BE 0885.857.745
Zedelgem · Eq €223k
APOTHEEK AMERICA ISABEL
BE 0698.711.685
Landen · Eq €224k
Pharmacie Henri Ledoux
BE 0422.129.449
Fontaine-l'Evêque · Eq €223k
Apotheek Rechtstro
BE 0458.789.610
Lochristi · Eq €223k
R&B FARMA
BE 0809.126.191
Antwerpen · Eq €223k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,546 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-04-2022
Fiscal year end30-06
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.